oxypurinol has been researched along with Urinary-Calculi* in 2 studies
1 review(s) available for oxypurinol and Urinary-Calculi
| Article | Year |
|---|---|
Etiopathogenesis of uncommon canine uroliths. Xanthine, carbonate, drugs, and drug metabolites.
Metabolic disorders, medication, and diagnostic agents may be associated with urolithiasis in dogs. Examples of uroliths that have been uncommonly encountered in dogs include xanthine, dolomite, tetracycline, and sulfonamides. Detection of these and other apparently uncommon uroliths requires a high index of suspicion and proper methods of analysis. Topics: Adenine; Animals; Calcium Carbonate; Dog Diseases; Dogs; Oxypurinol; Sulfonamides; Tetracycline; Triamterene; Urinary Calculi; Xanthines | 1986 |
1 other study(ies) available for oxypurinol and Urinary-Calculi
| Article | Year |
|---|---|
Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300.
Disturbances in purine metabolism with hyperuricaemia and/or hyperuricosuria are a risk factor in uric acid and Ca oxalate stone formation. By way of a competitive xanthine oxidase inhibition, the formation of uric acid is reduced by allopurinol. In investigations on two groups of patients, Milurit could be demonstrated to decrease the uric acid levels in serum and urine. No differences could be seen in the dosages of 3 x 100 mg or 1 x 300 mg Milurit. Therefore, in stone recurrence prevention, the administration of Milurit 300 is recommended. Topics: Adolescent; Adult; Aged; Allopurinol; Calcium Oxalate; Female; Humans; Male; Middle Aged; Oxypurinol; Recurrence; Uric Acid; Urinary Calculi; Xanthine Oxidase | 1983 |